Atlas Trials

Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma

Clinical trial NCT03130270 · UNKNOWN

Trial details

NCT number
NCT03130270
Sponsor
Guilin Medical University, China
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2017-01-01
Primary completion
2019-04-08
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.